The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (7.89) USD. With the latest stock price at 0.90 USD, the upside of Cytosorbents Corp based on DCF is -972.1%.
Based on the latest price of 0.90 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 972.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.9% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (31.81) - (4.67) | (7.89) |
| Upside | -3618.1% - -616.8% | -972.1% |